Microscope High-Content Screening (Q3102678): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: import item from Luxembourg) |
(Changed label, description and/or aliases in en: Setting new description) |
||
| description / en | description / en | ||
Project in Luxembourg | Project Q3102678 in Luxembourg | ||
Revision as of 14:32, 14 September 2021
Project Q3102678 in Luxembourg
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Microscope High-Content Screening |
Project Q3102678 in Luxembourg |
Statements
300,000.0 Euro
0 references
750,000.0 Euro
0 references
40.0 percent
0 references
1 November 2018
0 references
1 July 2019
0 references
Luxembourg Institute of Health - LIH
0 references
The primary goal of the project is to etablish at LIH a fully operational and translational PDM-HCS platform, enabling personalised early drug discovery with a capacity to run a maximum of 10 projects in parallel to meet the many needs of scientific projects conducted in Luxembourg. The LIH platform will provide all academic and industrial scientists in Luxembourg with the opportunity to accelerate their advanced research projects in strategic areas as oncology, infectious disease and neurodegenerative disease. (English)
0 references
Identifiers
21
0 references